Identification and analysis of pancreatic intraepithelial neoplasia: opportunities and challenges

Pancreatic intraepithelial neoplasia (PanIN) is the most common precursor lesion of pancreatic ductal adenocarcinoma (PDAC), which has poor prognosis with a short median overall survival of 6-12 months and a low 5-year survival rate of approximately 3%. It is crucial to remove PanIN lesions to preve...

Full description

Saved in:
Bibliographic Details
Main Authors: Ling-ling Pian, Mei-hui Song, Teng-fei Wang, Ling Qi, Tie-li Peng, Ke-ping Xie
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2024.1401829/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841556852779778048
author Ling-ling Pian
Ling-ling Pian
Mei-hui Song
Teng-fei Wang
Teng-fei Wang
Ling Qi
Tie-li Peng
Ke-ping Xie
author_facet Ling-ling Pian
Ling-ling Pian
Mei-hui Song
Teng-fei Wang
Teng-fei Wang
Ling Qi
Tie-li Peng
Ke-ping Xie
author_sort Ling-ling Pian
collection DOAJ
description Pancreatic intraepithelial neoplasia (PanIN) is the most common precursor lesion of pancreatic ductal adenocarcinoma (PDAC), which has poor prognosis with a short median overall survival of 6-12 months and a low 5-year survival rate of approximately 3%. It is crucial to remove PanIN lesions to prevent the development of invasive PDAC, as PDAC spreads rapidly outside the pancreas. This review aims to provide the latest knowledge on PanIN risk, pathology, cellular origin, genetic susceptibility, and diagnosis, while identifying research gaps that require further investigation in this understudied area of precancerous lesions. PanINs are classified into PanIN 1, PanIN 2, and PanIN 3, with PanIN 3 having the highest likelihood of developing into invasive PDAC. Differentiating between PanIN 2 and PanIN 3 is clinically significant. Genetic alterations found in PDAC are also present in PanIN and increase with the grade of PanIN. Imaging methods alone are insufficient for distinguishing PanIN, necessitating the use of genetic and molecular tests for identification. In addition, metabolomics technologies and miRNAs are playing an increasingly important role in the field of cancer diagnosis, offering more possibilities for efficient identification of PanIN. Although detecting and stratifying the risk of PanIN poses challenges, the combined utilization of imaging, genetics, and metabolomics holds promise for improving patient survival in this field.
format Article
id doaj-art-3693bcac1aa94dc4afa7f0fd45485b6e
institution Kabale University
issn 1664-2392
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj-art-3693bcac1aa94dc4afa7f0fd45485b6e2025-01-07T05:23:57ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922025-01-011510.3389/fendo.2024.14018291401829Identification and analysis of pancreatic intraepithelial neoplasia: opportunities and challengesLing-ling Pian0Ling-ling Pian1Mei-hui Song2Teng-fei Wang3Teng-fei Wang4Ling Qi5Tie-li Peng6Ke-ping Xie7School of Medicine, The South China University of Technology, Guangzhou, Guangdong, ChinaDivision of Gastroenterology, Institute of Digestive Disease, Affiliated Qingyuan Hospital, The Sixth Clinical Medical School, Guangzhou Medical University, Qingyuan People’s Hospital, Qingyuan, Guangdong, ChinaDivision of Gastroenterology, Institute of Digestive Disease, Affiliated Qingyuan Hospital, The Sixth Clinical Medical School, Guangzhou Medical University, Qingyuan People’s Hospital, Qingyuan, Guangdong, ChinaDivision of Gastroenterology, Institute of Digestive Disease, Affiliated Qingyuan Hospital, The Sixth Clinical Medical School, Guangzhou Medical University, Qingyuan People’s Hospital, Qingyuan, Guangdong, ChinaShandong Laboratory of Yantai Drug Discovery, Bohai Rim Advanced Research Institute for Drug Discovery, Yantai, Shandong, ChinaDivision of Gastroenterology, Institute of Digestive Disease, Affiliated Qingyuan Hospital, The Sixth Clinical Medical School, Guangzhou Medical University, Qingyuan People’s Hospital, Qingyuan, Guangdong, ChinaDivision of Gastroenterology, Institute of Digestive Disease, Affiliated Qingyuan Hospital, The Sixth Clinical Medical School, Guangzhou Medical University, Qingyuan People’s Hospital, Qingyuan, Guangdong, ChinaSchool of Medicine, The South China University of Technology, Guangzhou, Guangdong, ChinaPancreatic intraepithelial neoplasia (PanIN) is the most common precursor lesion of pancreatic ductal adenocarcinoma (PDAC), which has poor prognosis with a short median overall survival of 6-12 months and a low 5-year survival rate of approximately 3%. It is crucial to remove PanIN lesions to prevent the development of invasive PDAC, as PDAC spreads rapidly outside the pancreas. This review aims to provide the latest knowledge on PanIN risk, pathology, cellular origin, genetic susceptibility, and diagnosis, while identifying research gaps that require further investigation in this understudied area of precancerous lesions. PanINs are classified into PanIN 1, PanIN 2, and PanIN 3, with PanIN 3 having the highest likelihood of developing into invasive PDAC. Differentiating between PanIN 2 and PanIN 3 is clinically significant. Genetic alterations found in PDAC are also present in PanIN and increase with the grade of PanIN. Imaging methods alone are insufficient for distinguishing PanIN, necessitating the use of genetic and molecular tests for identification. In addition, metabolomics technologies and miRNAs are playing an increasingly important role in the field of cancer diagnosis, offering more possibilities for efficient identification of PanIN. Although detecting and stratifying the risk of PanIN poses challenges, the combined utilization of imaging, genetics, and metabolomics holds promise for improving patient survival in this field.https://www.frontiersin.org/articles/10.3389/fendo.2024.1401829/fullPanINPDACKRAScellular origingenetic susceptibilitydiagnosis
spellingShingle Ling-ling Pian
Ling-ling Pian
Mei-hui Song
Teng-fei Wang
Teng-fei Wang
Ling Qi
Tie-li Peng
Ke-ping Xie
Identification and analysis of pancreatic intraepithelial neoplasia: opportunities and challenges
Frontiers in Endocrinology
PanIN
PDAC
KRAS
cellular origin
genetic susceptibility
diagnosis
title Identification and analysis of pancreatic intraepithelial neoplasia: opportunities and challenges
title_full Identification and analysis of pancreatic intraepithelial neoplasia: opportunities and challenges
title_fullStr Identification and analysis of pancreatic intraepithelial neoplasia: opportunities and challenges
title_full_unstemmed Identification and analysis of pancreatic intraepithelial neoplasia: opportunities and challenges
title_short Identification and analysis of pancreatic intraepithelial neoplasia: opportunities and challenges
title_sort identification and analysis of pancreatic intraepithelial neoplasia opportunities and challenges
topic PanIN
PDAC
KRAS
cellular origin
genetic susceptibility
diagnosis
url https://www.frontiersin.org/articles/10.3389/fendo.2024.1401829/full
work_keys_str_mv AT linglingpian identificationandanalysisofpancreaticintraepithelialneoplasiaopportunitiesandchallenges
AT linglingpian identificationandanalysisofpancreaticintraepithelialneoplasiaopportunitiesandchallenges
AT meihuisong identificationandanalysisofpancreaticintraepithelialneoplasiaopportunitiesandchallenges
AT tengfeiwang identificationandanalysisofpancreaticintraepithelialneoplasiaopportunitiesandchallenges
AT tengfeiwang identificationandanalysisofpancreaticintraepithelialneoplasiaopportunitiesandchallenges
AT lingqi identificationandanalysisofpancreaticintraepithelialneoplasiaopportunitiesandchallenges
AT tielipeng identificationandanalysisofpancreaticintraepithelialneoplasiaopportunitiesandchallenges
AT kepingxie identificationandanalysisofpancreaticintraepithelialneoplasiaopportunitiesandchallenges